An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

The European Medicines Agency accepts GSK's regulatory filing for expanded use of Nucala to treat COPD for review.

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...

CStone Pharmaceuticals ('CStone', HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool ...

First patient dosed in Phase II OCULE-01 study with roginolisib, an allosteric modulator of PI3KdThe European Medicines Agency (EMA) has granted Orphan Drug Designation for roginolisib for treatment ...

Fostering dialogue between neurologists, researchers, patient representatives, and policymakers is an important step towards ...

The EU lacks cohesive governance to deploy economic statecraft tools, such as sanctions and export controls, undermining ...